Myocardial fibrosis in endomyocardial biopsy specimens: Do different bioptomes affect estimation?

C. R. Meckel, J. G. Rogers, J. E. Wilson, T. J. Goaley, T. D. Sears, B. M. McManus

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Estimation of fibrosis in endomyocardial biopsy specimens (EMB) is integral to their assesment; typically, EMB fibrosis is assessed qualitatively. We quantitated percent fibrosis in 697 paraffin-embedded, Masson's trichrome stained EMB taken from 6 sites along the right ventricular septum and from 1 site in the left ventricular free wall, utilizing Caves-Schultz(TM) (C-S) and Cordis(TM) (C) bioptomes and a scalpel in 34 formaldehyde-fixed autopsy hearts, 22 of which were anatomically normal (AN) and 7 of which were idiopathically dilated. Total tissue area and area of fibrosis were quantitated by computer-based image analysis. The mean total areas as obtained by the C-S and C bioptomes and scalpel were 0.0535 cm2 (± 0.028), 0.0338 cm2 (± 0.020), and 0.4370 cm2 (± 0.144), respectively. The C-S and C bioptomes and the scalpel from all hearts yielded percent fibrosis of 10.6, 12.3 and 5.4, respectively. The AN hearts had percents of 9.3, 11.8, and 4.5, while the ID hearts had 11.0, 13.7, and 7.3% fibrosis, respectively, by each sampling method. A consistent pattern was observed: the larger the piece of endomyocardium, i.e., scalpel > CS > C, the lesser the quantitated percent fibrosis. Thus, beyond allowing for biological variability in the degree of endomyocardial fibrosis, the impact of EMB size and the bioptome type must be accommodated in qualitative surgical reports pertaining to myopathic hearts.

Original languageEnglish (US)
Pages (from-to)309-313
Number of pages5
JournalAmerican Journal of Cardiovascular Pathology
Volume2
Issue number4
StatePublished - 1989

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Myocardial fibrosis in endomyocardial biopsy specimens: Do different bioptomes affect estimation?'. Together they form a unique fingerprint.

  • Cite this

    Meckel, C. R., Rogers, J. G., Wilson, J. E., Goaley, T. J., Sears, T. D., & McManus, B. M. (1989). Myocardial fibrosis in endomyocardial biopsy specimens: Do different bioptomes affect estimation? American Journal of Cardiovascular Pathology, 2(4), 309-313.